Why is age alone not the question?
Mounjaro is not forbidden simply because you are over 60, but older adults are not one group. One person of 66 walks daily and manages their own affairs; another of 76 has weak muscles, unintended weight loss and three blood-pressure medicines. Both may have obesity, yet the decision and the plan should not be identical. What matters is muscle mass and strength, mobility and balance, kidney health, current medicines, appetite and food intake, and any history of falls. The goal of weight loss matters too: is it better movement, breathing and blood sugar, or only a lower number on the scale? The difference between a robust older adult and a frail one is not a birth date but functional reserve: muscle, heart, kidneys and brain. A good review therefore looks at these factors before discussing any medicine, and decides whether nutrition assessment, physiotherapy or a medication review should come first. The better question is not “What age is allowed?” but “What needs checking in someone with my age and my health?” [1, 3, 4]
What the Mounjaro label reports for people 65 and over
The prescribing information pools seven clinical trials. In that pool, 1,539 people treated with Mounjaro were 65 or older (30.1%), and 212 were 75 or older (4.1%). The label says no overall difference in safety or efficacy was detected between these patients and younger ones, but it also warns that greater sensitivity in some older individuals cannot be ruled out. Both halves of that sentence matter: the average result showed no clear difference, while individual sensitivity remains possible. The practical conclusion is not one rule for everyone over 65, but closer attention to symptoms, nutrition and kidney function. The label also lists clear contraindications, and it advises monitoring kidney function in people who report side effects that could lead to fluid loss. There is no upper age limit in the label; there are data and cautions. A trial percentage is neither an automatic permission nor an automatic prohibition. [1]
Muscle: not all weight lost is fat
With any effective weight-loss method, some of the weight lost is muscle. In a substudy of SURMOUNT-1, 160 participants had body composition measured by DXA over 72 weeks. The tirzepatide group lost 21.3% of body weight, 33.9% of fat mass and 10.9% of lean mass. About 75% of the weight lost was fat and 25% was lean mass, and that proportion was consistent in most subgroup analyses, which included people 65 and older. This does not mean muscle “melts away,” or that every older adult will lose the same proportion. It does mean that strength and mobility deserve follow-up, not only the scale. When excess adiposity coexists with low muscle mass or poor muscle function, the medical term is sarcopenic obesity; the ESPEN/EASO consensus calls for assessing muscle and function, not weight alone. A NEJM trial of 107 adults aged 65 or older found that weight loss combined with exercise improved physical performance more than diet alone, and reduced the loss of lean mass and hip bone density. Physical performance rose 21% with diet plus exercise, compared with 12% with diet alone and 15% with exercise alone. Exercise and nutrition support are therefore part of the plan, not an optional extra. [2, 3, 5] Our article on protecting muscle during weight loss explains the exercise and protein side in more detail.
Falls: a risk to assess before it happens
WHO estimates that about 842,000 people died from falls worldwide in 2023, that about 71% of those deaths were among adults aged 60 and older, and that falls are the second-leading cause of unintentional injury death after road traffic injuries. These figures are not meant to alarm you. They show that a fall is not a trivial part of growing older. The World Falls Guidelines advise that all older adults receive advice on falls prevention and physical activity, and that those at higher risk receive a comprehensive multifactorial assessment. That assessment covers previous falls, balance and walking, vision, home hazards, footwear, and medicines that affect blood pressure or alertness. A medication review by itself is not enough, and one change should not be expected to solve everything; it belongs within a multidomain plan. [9, 10, 11] If you have osteoporosis or a previous fracture, our article on Mounjaro and bone health adds useful detail. The key point is that any weight-loss plan for you should include a conversation about falls and balance.
Dehydration and kidneys: why follow-up matters
Dehydration is one of the risks that grows in older adults with any medicine that reduces appetite or causes vomiting or diarrhoea. The label warns about acute kidney injury caused by volume depletion, and it asks clinicians to monitor kidney function in people who report side effects that could lead to fluid loss. The point is not that the medicine directly damages the kidney. Vomiting, diarrhoea and poor drinking can reduce body fluid, and the kidneys then feel the strain. Older adults are already more vulnerable to low fluid intake because thirst sensation declines, some medicines are diuretics, and some people deliberately drink less to avoid frequent trips to the toilet. The ESPEN geriatrics guideline says every older person should be considered at risk of low-intake dehydration and encouraged to drink adequate amounts. “Drink plenty” is not a safe universal rule, however, if you have heart failure or a prescribed fluid limit; ask your team. [1, 6] Our article on Mounjaro, kidneys and dehydration explains the warning signs and the tests that may be needed.
Medicines: review before starting, not after a problem
Older adults often take several medicines. That is not a fault in anyone, but it is a fact that deserves serious attention. The AGS Beers Criteria identify medicines that are best avoided or reviewed in certain situations for adults 65 and older, and they support shared decision-making rather than a list applied blindly to everyone. With Mounjaro specifically, the label warns about hypoglycaemia when it is used with insulin or a sulfonylurea, and says the clinician may need to reduce the insulin or sulfonylurea dose to lower that risk. That is a prescriber’s decision, not something to adjust yourself. The medicine also delays gastric emptying, which can affect the absorption of other medicines taken by mouth. Medicines with a narrow safety margin, such as warfarin, need closer monitoring. Before starting, write down everything you take: blood-pressure and diabetes medicines, pharmacy painkillers, vitamins and herbal products. [1, 8]
Appetite and nutrition: muscles need fuel
Reduced appetite is itself a common adverse reaction in the label, and in older adults it is a bigger issue than simply not feeling hungry. Loss of appetite with ageing is a recognised condition, and it can lead to low energy and protein intake, weakness and unintended weight loss. The PROT-AGE position paper recommends an average of 1.0–1.2 g of protein per kilogram of body weight per day for people over 65 to maintain muscle, with 1.2–1.5 g/kg in acute or chronic illness. An important exception is severe kidney disease (eGFR below 30) without dialysis, where protein may need to be limited. Those figures are general; your clinician or dietitian adjusts them to your weight, kidneys and other conditions. The ESPEN geriatrics guideline recommends malnutrition screening for every older person, says dietary restrictions should generally be avoided, and says a weight-reducing diet should be considered only in an older person with obesity and a weight-related health problem, together with exercise. [6, 7, 12] Our article on low appetite and protein with Mounjaro offers practical food ideas for when appetite drops.
The goal is not a number on the scale
When weight loss is discussed in later life, the priority is usually mobility, independence and quality of life, not reaching a particular weight. The ESPEN/EASO consensus on sarcopenic obesity calls for assessing function and muscle, not weight alone. The NEJM trial mentioned earlier showed that diet plus exercise improved physical performance more than either alone. A good plan therefore asks: can you stand up from a chair easily? Has your walking changed? Is your balance worse? Can you still climb the stairs as before? Have sleep, breathing, blood pressure and blood sugar improved? If weight is falling quickly without intention, especially alongside weakness, that calls for a pause and assessment, not celebration. No medicine promises to make you lighter and stronger at the same time without exercise, protein and follow-up. Success means preserving function and reducing risk, not simply forcing the number down. The goal should also be realistic, measurable and written into a plan you can return to. [3, 5]
Preparing for the visit: what to bring
A review visit works better when you bring the full picture instead of relying on memory. Write down your weight history over the past year, any unintended loss, how often you have vomited or had diarrhoea, and any fall or dizziness. Bring a list of every medicine and dose, including painkillers, vitamins and herbal products, plus earlier test results, especially kidney function, blood sugar and blood pressure. Tell the clinician clearly about any history of pancreatitis, gallstones, stomach problems, or a family history of medullary thyroid carcinoma or MEN2. Ask whether the medicine suits your situation, which symptoms should prompt concern, what follow-up is planned, and what to do if you cannot drink or eat. Do not start the medicine without a prescription, and do not stop it or change the dose on your own. [1, 6] Our article on tests and ultrasound before weight-loss injections explains the investigations a visit may involve.
A practical step at La Rose
If you are 60 or older and considering Mounjaro or another weight-loss medicine, you can begin with a medical review rather than an injection. At La Rose, weight-management follow-up including Mounjaro and Wegovy is available at the Maadi and Fifth Settlement branches after a consultation that reviews your history, tests and current medicines. The Maadi branch is at 14 El-Mokhtar Street, off El-Nasr Street, behind QNB Bank, New Maadi. The Fifth Settlement branch is in CMC Medical Mall, fourth floor, North 90th Street. Dr Shimaa Fouad provides nutrition and weight-management follow-up in Maadi on Saturday, Monday and Tuesday from 3 to 8 pm, and in Fifth Settlement on Wednesday from 3:30 to 8 pm. If you also need an internal-medicine and diabetes review, Dr Mohab Ashraf Fouad sees patients in Maadi on Saturday from 4 to 7 pm. The visit is not a promise of a prescription; it is an assessment of whether the medicine is suitable, what the alternatives are, and what follow-up is needed. Persistent vomiting, dizziness or passing very little urine should prompt urgent assessment before any routine booking. You can arrange the visit through the booking page and mention your medicines, kidney problems or any previous fall. [1, 6]
